119 related articles for article (PubMed ID: 3323072)
1. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
[TBL] [Abstract][Full Text] [Related]
2. Combined beta 1-adrenoceptor blockade and/or beta 2- or beta 1/2 adrenoceptor stimulation as treatment of essential hypertension.
Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
J Hypertens Suppl; 1988 Dec; 6(4):S658-61. PubMed ID: 2853764
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
Pfisterer M; Burkart F; Bühler FR; Schweizer W
Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
[TBL] [Abstract][Full Text] [Related]
4. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the antihypertensive effects of indapamide and metoprolol.
Kubik MM; Coote JH
Postgrad Med J; 1981; 57 Suppl 2():44-50. PubMed ID: 7033946
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
Lavenius B; Hansson L
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
9. Metoprolol in hypertension: an open evaluation.
Assaykeen TA; Michell G
Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
[TBL] [Abstract][Full Text] [Related]
10. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
[TBL] [Abstract][Full Text] [Related]
11. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
Hoffmann J
Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
14. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
[TBL] [Abstract][Full Text] [Related]
15. [Exercise performance after long-term administration of enalapril or metoprolol. A randomized double-blind study of hypertensive leisure-time sportsmen].
Teixeira A; Billigmann PW; Bohner H; Schumacher H
Dtsch Med Wochenschr; 1992 Jun; 117(25):967-73. PubMed ID: 1611965
[TBL] [Abstract][Full Text] [Related]
16. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
[TBL] [Abstract][Full Text] [Related]
17. [The effect of OROS metoprolol in mild and moderately severe essential hypertension].
Hradec J; Král J; Petrásek J
Cas Lek Cesk; 1990 Jun; 129(23):709-13. PubMed ID: 2393874
[TBL] [Abstract][Full Text] [Related]
18. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
Sjöberg KH
Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
Dafgärd T; Forsén B; Lindahl T
Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
[TBL] [Abstract][Full Text] [Related]
20. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
McKenna F; Davison AM
Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
